Sumitomo Pharma America, Inc.(formerly Sunovion Pharmaceuticals Inc.) lobbies on its own behalf. For Q1 2024 it reported $210K across 1 client report and lists 3 lobbyists across its filings. Issues include Health Issues.
| Client | Reported | Issues |
|---|---|---|
| SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.) | $210K | Health Issues |
| Year | Reported | Clients |
|---|---|---|
| 2024 | $210K | 1 |
| 2023 | $1.09M | 1 |
| 2022 | $1.31M | 1 |
| 2021 | $1.14M | 1 |
| 2020 | $1.14M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.